New Key Statistics Module, Z-Score and F-Score
SZSE:301258 Key Ratios
Market Cap ¥ M | 1,925.07 |
Enterprise Value ¥ M | 541.60 |
P/E(ttm) | 29.17 |
PE Ratio without NRI | 27.81 |
Forward PE Ratio | -- |
Price/Book | 0.99 |
Price/Sales | 4.49 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 116.02 |
Payout Ratio % | 0.77 |
Revenue (TTM) ¥ M | 429.00 |
EPS (TTM) ¥ | 0.72 |
Beneish M-Score | -1.57 |
10-y EBITDA Growth Rate % | 18.30 |
5-y EBITDA Growth Rate % | -0.90 |
y-y EBITDA Growth Rate % | -65.40 |
EV-to-EBIT | 7.24 |
EV-to-EBITDA | 7.24 |
PEG | -- |
Shares Outstanding M | 91.67 |
Net Margin (%) | 15.47 |
Operating Margin % | 10.83 |
Pre-tax Margin (%) | 17.42 |
Quick Ratio | 15.40 |
Current Ratio | 17.00 |
ROA % (ttm) | 3.13 |
ROE % (ttm) | 3.42 |
ROIC % (ttm) | 7.12 |
Dividend Yield % | 2.85 |
Altman Z-Score | 9.24 |
SZSE:301258 Number of Guru Trades
SZSE:301258 Volume of Guru Trades
Gurus Latest Trades with SZSE:301258
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301258 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Suzhou Fushilai Pharmaceutical Co Ltd Insider Transactions
No Available Data